Baird Financial Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Baird Financial Group’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-83,737	Closed	-$1.6M	–	1786
2022 Q3	$1.6M	Buy	83,737 +1,500	+2%	+$27.3K	﹤0.01%	909
2022 Q2	$1.25M	Buy	82,237 +4,430	+6%	+$65.5K	﹤0.01%	997
2022 Q1	$1.58M	Buy	77,807 +7,545	+11%	+$154K	﹤0.01%	976
2021 Q4	$2.05M	Buy	70,262 +7,644	+12%	+$219K	﹤0.01%	933
2021 Q3	$1.35M	Buy	62,618 +12,372	+25%	+$299K	﹤0.01%	1085
2021 Q2	$1.29M	Buy	50,246 +15,333	+44%	+$328K	﹤0.01%	1077
2021 Q1	$636K	Buy	+34,913	New	+$580K	﹤0.01%	1290

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Baird Financial Group's CDMO Position: Q4 2022 in Review

Baird Financial Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 83,737 shares — an estimated $1.6M sold.

Baird Financial Group first reported a position in CDMO in Q1 2021 and held it in 7 quarters. The position peaked at $2.05M in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

Baird Financial Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Baird Financial Group sold 83,737 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $1.6M.
Baird Financial Group first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Baird Financial Group's Avid Bioservices, Inc. Common Stock position peaked at $2.05M in Q4 2021.
168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Baird Financial Group's 13F filing for Q4 2022, filed 13 Feb 2023.